BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Annie A Wu, Virginia Drake, Huai-Shiuan Huang, ShihChi Chiu, Lei Zheng. Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cellsOncoImmunology 2015; 4(7): e1016700 doi: 10.1080/2162402X.2015.1016700
2
María José Carlini, Pablo Roitman, Myriam Nuñez, María Guadalupe Pallotta, Gastón Boggio, David Smith, Mariana Salatino, Elisa D. Bal de Kier Joffé, Gabriel A. Rabinovich, Lydia I. Puricelli. Clinical relevance of galectin-1 expression in non-small cell lung cancer patientsLung Cancer 2014; 84(1): 73 doi: 10.1016/j.lungcan.2014.01.016
3
Lucile Astorgues-Xerri, Maria E. Riveiro, Annemilaï Tijeras-Raballand, Maria Serova, Gabriel A. Rabinovich, Ivan Bieche, Michel Vidaud, Armand de Gramont, Mathieu Martinet, Esteban Cvitkovic, Sandrine Faivre, Eric Raymond. OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesisEuropean Journal of Cancer 2014; 50(14): 2463 doi: 10.1016/j.ejca.2014.06.015
4
Stefan Kasper, Martin Schuler. Cancer Immunotherapy Meets Oncology2014; : 179 doi: 10.1007/978-3-319-05104-8_17
5
Jonathan W. Riess, Christina S. Kong, Robert B. West, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Quynh-Thu Le. Increased Galectin-1 Expression in Thymic Epithelial TumorsClinical Lung Cancer 2019; 20(3): e356 doi: 10.1016/j.cllc.2018.12.005
6
Rongzu Wu, Tingchun Wu, Kai Wang, Shicheng Luo, Zhen Chen, Min Fan, Dong Xue, Hao Lu, Qianfeng Zhuang, Xianlin Xu. Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysisCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0607-y
7
Bo Long, Zeyuan Yu, Huinian Zhou, Zhijian Ma, Yanxian Ren, Hao Zhan, Long Li, Hongtai Cao, Zuoyi Jiao. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysisInternational Journal of Surgery 2018; 56: 242 doi: 10.1016/j.ijsu.2018.06.033
8
Ali Akbar Esmailiejah, Afshin Taheriazam, Mohammad Reza Golbakhsh, Mohammad Jamshidi, Mohammadreza Shakeri, Emad Yahaghi, Mehdi Moghtadaei. RETRACTED ARTICLE: Analysis of serum levels and tissue expression of galectin-1 and galectin-3 as noninvasive biomarkers in osteosarcoma patientsTumor Biology 2016; 37(12): 16389 doi: 10.1007/s13277-015-4194-4
9
Stefan Kasper, Martin Schuler. Targeted therapies in gastroesophageal cancerEuropean Journal of Cancer 2014; 50(7): 1247 doi: 10.1016/j.ejca.2014.01.009
10
Reza Ranjbar, Foroogh Nejatollahi, Ahmad Sina Nedaei Ahmadi, Hossein Hafezi, Akbar Safaie. Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical SignificanceIranian Journal of Cancer Prevention 2015; 8(4) doi: 10.17795/ijcp-3428
11
Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri. Proposed Molecular and miRNA Classification of Gastric CancerInternational Journal of Molecular Sciences 2018; 19(6): 1683 doi: 10.3390/ijms19061683
12
Lucile Astorgues-Xerri, Maria E. Riveiro, Annemilaï Tijeras-Raballand, Maria Serova, Cindy Neuzillet, Sébastien Albert, Eric Raymond, Sandrine Faivre. Unraveling galectin-1 as a novel therapeutic target for cancerCancer Treatment Reviews 2014; 40(2): 307 doi: 10.1016/j.ctrv.2013.07.007
13
Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapyOncotarget 2015; 6(28): 24750 doi: 10.18632/oncotarget.4990
14
Zhaohui Jin, Harry H. Yoon. Antiangiogenic Therapy in Gastroesophageal CancerHematology/Oncology Clinics of North America 2017; 31(3): 499 doi: 10.1016/j.hoc.2017.01.008
15
Yu-Li Su, Hao-Lun Luo, Chun-Chieh Huang, Ting-Ting Liu, Eng-Yen Huang, Ming-Tse Sung, Jen-Jie Lin, Po-Hui Chiang, Yen-Ta Chen, Chih-Hsiung Kang, Yuan-Tso Cheng. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and SurvivalCells 2020; 9(4): 806 doi: 10.3390/cells9040806
16
Sadhna Aggarwal, Suresh C. Sharma, Satya N. Das. Galectin-1 and galectin-3: Plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk populationClinica Chimica Acta 2015; 442: 13 doi: 10.1016/j.cca.2014.12.038
17
Hong Jun Kim, Sang Cheul Oh. Novel Systemic Therapies for Advanced Gastric CancerJournal of Gastric Cancer 2018; 18(1): 1 doi: 10.5230/jgc.2018.18.e3
18
Victor L. Thijssen, Roy Heusschen, Jo Caers, Arjan W. Griffioen. Galectin expression in cancer diagnosis and prognosis: A systematic reviewBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1855(2): 235 doi: 10.1016/j.bbcan.2015.03.003
19
Lara Alessandrini, Melissa Manchi, Fabrizio Italia, Tiziana Perin, Vincenzo Canzonieri. Gastric Cancer In The Precision Medicine EraCurrent Clinical Pathology 2019; : 155 doi: 10.1007/978-3-030-04861-7_10
20
Elizabeth Cartwright, Avani Athauda, Ian Chau. Emerging precision therapies for gastric cancerExpert Review of Precision Medicine and Drug Development 2020; 5(4): 299 doi: 10.1080/23808993.2020.1760089
21
Jia Li, Xiaopan Yao, Jeremy S. Kortmansky, Neal A. Fischbach, Stacey Stein, Yanhong Deng, Yue Zhang, Indukala Doddamane, David Karimeddini, Howard S. Hochster, Jill Lacy. Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal AdenocarcinomaAmerican Journal of Clinical Oncology 2017; 40(2): 146 doi: 10.1097/COC.0000000000000114
22
Cherylane Dubé-Delarosbil, Yves St-Pierre. The emerging role of galectins in high-fatality cancersCellular and Molecular Life Sciences 2018; 75(7): 1215 doi: 10.1007/s00018-017-2708-5
23
Mariana Ferreira Leal, Fernanda Wisnieski, Carolina de Oliveira Gigek, Leonardo Caires do Santos, Danielle Queiroz Calcagno, Rommel Rodriguez Burbano, Marilia Cardoso Smith. What gastric cancer proteomic studies show about gastric carcinogenesis?Tumor Biology 2016; 37(8): 9991 doi: 10.1007/s13277-016-5043-9
24
Yang Chong, Dong Tang, Jun Gao, Xuetong Jiang, Chuanqi Xu, Qingquan Xiong, Yuqin Huang, Jie Wang, Huaicheng Zhou, Youquan Shi, Daorong Wang. Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathwayOncotarget 2016; 7(50): 83611 doi: 10.18632/oncotarget.13201
25
Alexandra Thiel, Ari Ristimäki. Targeted therapy in gastric cancerAPMIS 2015; 123(5): 365 doi: 10.1111/apm.12359
26
Kun Zou, Shuailong Yang, Liang Zheng, Chaogang Yang, Bin Xiong. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system reviewBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2772-5
27
Ya-nan Ji, Qin Wang, Yang Li, Zhi Wang. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysisTumor Biology 2014; 35(3): 2787 doi: 10.1007/s13277-013-1371-1
28
Paulina Sindrewicz, Lu-Yun Lian, Lu-Gang Yu. Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and MetastasisFrontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00079
29
Kun-Hung Shen, Chien-Feng Li, Lan-Hsiang Chien, Cheng-Hao Huang, Chia-Cheng Su, Alex C. Liao, Ting-Feng Wu. Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathwayCancer Science 2016; 107(10): 1390 doi: 10.1111/cas.13016
30
Hua Tian, Yan Zhou, Gaoxiang Yang, Yang Geng, Sai Wu, Yabin Hu, Kai Lin, Wei Wu. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cellsOncology Reports 2016; 36(3): 1361 doi: 10.3892/or.2016.4942
31
Daniel H. Ahn, Tanios Bekaii-Saab. Esophageal Cancer2020; : 275 doi: 10.1007/978-3-030-29832-6_14
32
Suk-young Lee, Sang Cheul Oh. Changing strategies for target therapy in gastric cancerWorld Journal of Gastroenterology 2016; 22(3): 1179-1189 doi: 10.3748/wjg.v22.i3.1179
33
Ming‐Yu Huang, Jia‐Peng He, Wen‐Qian Zhang, Ji‐Long Liu. Pooling analysis reveals that galectin‐1 is a reliable prognostic biomarker in various cancersJournal of Cellular Physiology 2019; 234(8): 13788 doi: 10.1002/jcp.28059